TCMBANKIN000002 |
rubiarbonone c |
|
C32H50O5 |
514.7 g/mol |
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CCC(=O)C5(C)C)C)O)C)C)COC(=O)C)O |
TCMBANKIN001606 |
2-Methyl-1,3,6-trihydroxy-9,10-anthraqui-none-3-O-beta-D-xylosyl-(1-->2)-beta-D-(6'-O-acetyl) glucoside |
acetic acid [(2R,3S,4S,5R,6S)-6-[(4,7-dihydroxy-9,10-diketo-3-methyl-2-anthryl)oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methyl ester; acetic acid [(2R,3S,4S,5R,6S)-6-[(4,7-dihydroxy-3-methyl-9,10-dioxo-2-anthryl)oxy]-3,4-dihydroxy-5-[[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]methyl ester; [(2R,3S,4S,5R,6S)-6-(4,7-dihydroxy-3-methyl-9,10-dioxo-anthracen-2-yl)oxy-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-oxan-2-yl]methyl ethanoate; [(2R,3S,4S,5R,6S)-6-(4,7-dihydroxy-3-methyl-9,10-dioxoanthracen-2-yl)oxy-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]methyl acetate; [(2R,3S,4S,5R,6S)-6-[(4,7-dihydroxy-3-methyl-9,10-dioxo-2-anthryl)oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methyl acetate |
|
606.58 |
|
TCMBANKIN016743 |
rubia akanera-xii |
|
C46H58N6O14 |
|
|
TCMBANKIN018817 |
5′-Methoxylariciresinol |
|
|
|
|
TCMBANKIN021504 |
rubia akanera-v |
|
C40H48N6O9 |
|
|
TCMBANKIN037661 |
rubianthraquinone |
|
C16H12O5 |
284.26 g/mol |
CC1=C(C=C2C(=C1OC)C(=O)C3=C(C2=O)C=C(C=C3)O)O |
TCMBANKIN037763 |
Rubiarbonol A |
|
|
474.72 |
|
TCMBANKIN037803 |
Rubiarboside G |
|
|
799 g/mol |
|
TCMBANKIN038358 |
Rubianol A |
|
|
488.7 g/mol |
|
TCMBANKIN038520 |
rubiarboside a |
|
C38H62O10 |
|
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CC(C(C5(C)C)OC6C(C(C(C(O6)CO)O)O)O)OC(=O)C)C)O)C)C)C)O |
TCMBANKIN038761 |
rubianoside ii |
|
C36H60O8 |
620.9 g/mol |
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)C)C)O |
TCMBANKIN039224 |
Rubiarbonol F |
|
|
490.7 g/mol |
|
TCMBANKIN039275 |
Rubianol B |
|
|
530.7 g/mol |
|
TCMBANKIN040250 |
Rubiarbonol B |
|
|
458.7 g/mol |
|
TCMBANKIN041131 |
Rubianoside III |
|
|
636.9 g/mol |
|
TCMBANKIN041177 |
Rubinaphthin C |
|
|
482.4 g/mol |
|
TCMBANKIN041235 |
Rubiarbonone F |
|
|
486.7 g/mol |
|
TCMBANKIN041488 |
rubianoside i |
|
C38H60O10 |
676.9 g/mol |
CC(C)C1CC2C3C1(CCC4(C3(CC=C5C4C(CC6C5(CC(C(C6(C)C)OC7C(C(C(C(O7)CO)O)O)O)OC(=O)C)C)O)C)C)CO2 |
TCMBANKIN042037 |
2-o-acetyl-28-dehydroxy-rubianoside iv |
|
C38H62O10 |
|
|
TCMBANKIN042232 |
Rubinaphthin D |
|
|
644.6 g/mol |
|
TCMBANKIN043422 |
rubinaphthin b |
|
C22H28O12 |
484.4 g/mol |
C1=CC=C2C(=C1)C(=CC=C2OC3C(C(C(C(O3)CO)O)O)O)OC4C(C(C(C(O4)CO)O)O)O |
TCMBANKIN043919 |
Rubiarbonone D |
|
|
456.7 g/mol |
|
TCMBANKIN045105 |
2-O-Acetyl-rubianoside IV |
|
|
|
|
TCMBANKIN045568 |
rubinaphthin a |
|
C17H18O9 |
366.3 g/mol |
C1=CC=C2C(=C1)C(=CC(=C2O)C(=O)O)OC3C(C(C(C(O3)CO)O)O)O |
TCMBANKIN045785 |
rubiarbonone b |
|
C30H48O4 |
472.7 g/mol |
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CCC(=O)C5(C)C)C)O)C)C)CO)O |
TCMBANKIN045931 |
rubianoside iv |
|
C36H60O10 |
652.9 g/mol |
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CC(C(C5(C)C)OC6C(C(C(C(O6)CO)O)O)O)O)C)O)C)C)CO)O |
TCMBANKIN046002 |
rubianol c |
|
C32H52O5 |
516.8 g/mol |
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CCC(C5(C)C)O)C)O)C)C)COC(=O)C)O |
TCMBANKIN046633 |
Rubiarbonone A |
|
|
514.7 g/mol |
|
TCMBANKIN046936 |
Rubianol E |
|
|
574.8 g/mol |
|
TCMBANKIN047888 |
rubiarbonone c' |
|
C32H50O5 |
|
|
TCMBANKIN048130 |
Rubianol D |
|
|
532.8 g/mol |
|
TCMBANKIN049049 |
2-o-acetyl-28-o-acetyl-rubianoside iv |
|
C40H64O12 |
|
|
TCMBANKIN049171 |
rubiarbonol g |
|
C32H52O5 |
516.8 g/mol |
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CCC(C5(C)C)O)C)O)C)C)CO)OC(=O)C |
TCMBANKIN059202 |
rubiarbonone e |
rubianol g |
C30H46O4 |
470.7 g/mol |
CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(C=CC(=O)C5(C)C)C)O)C)C)CO)O |
TCMBANKIN060679 |
stigmasterol |
|
C29H48O |
412.7 g/mol |
CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
TCMBANKIN061547 |
(+)-isolariciresinol;(2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-2,3-dimethylol-tetralin-6-ol;isolariciresinol |
26568-14-9; (6R,7R,8S)-8-(4-hydroxy-3-methoxy-phenyl)-6,7-bis(hydroxymethyl)-3-methoxy-5,6,7,8-tetrahydronaphthalen-2-ol; 47477-27-0; (6R,7R,8S)-8-(4-hydroxy-3-methoxyphenyl)-6,7-bis(hydroxymethyl)-3-methoxy-5,6,7,8-tetrahydronaphthalen-2-ol; (2R,3R,4S)-4-(4-hydroxy-3-methoxyphenyl)-2,3-bis(hydroxymethyl)-7-methoxy-6-tetralinol; 2,3-Naphthalenedimethanol, 1,2,3,4-tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-6-methoxy-, (1S-(1alpha,2beta,3alpha))-; 548-29-8; Arbo 3; 1,2,3,4-Tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-6-methoxy-2,3-naphthalenedimethanol; (2R,3R,4S)-4-(4-hydroxy-3-methoxy-phenyl)-2,3-bis(hydroxymethyl)-7-methoxy-tetralin-6-ol |
C20H24O6 |
360.4 |
COC1=C(C=C2C(C(C(CC2=C1)CO)CO)C3=CC(=C(C=C3)O)OC)O |
TCMBANKIN061561 |
vanillic acid |
CJ-02984; CHEBI:16632; Vanillate; CHEBI:30816; H36001_ALDRICH; InChI=1/C8H8O4/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,9H,1H3,(H,10,11; BRN 2208364; WKOLLVMJNQIZCI-UHFFFAOYSA-M; 94770_FLUKA; WLN: QVR DQ CO1; MLS000574833; Acide vanillique; vanillicacid; C06672; m-Anisic acid, 4-hydroxy-; VA (VAN); vanil-lic acid; 4-Hydroxy-3-methoxybenzoic acidion; 4-Hydroxy-3-methoxybenzoic acid; Protocatechuic acid, 3-methyl ester; NSC3987; NSC 674322; DB02130; VANILLIC ACID; p-Vanillic acid; NSC 3987; ZB010900; 4-Hydroxy-3-methoxybenzoate; AIDS-018089; p-Hydroxy-m-methoxy-benzonic acid; 3-Methoxy-4-hydroxybenzoic acid; 4-hydroxy-3-methoxy-benzoic acid; NSC674322; 6746-48-1; 121-34-6; AC1L2LVA; Benzoic acid, 4-hydroxy-3-methoxy-; AI3-19542; SMR000156289; AIDS018089; SBB008280; W398802_ALDRICH; EINECS 204-466-8; 4-hydroxy-3-methoxy benzoic acid; 3-methoxy-4-hydroxybenzoic acid |
C8H8O4 |
168.15 g/mol |
COC1=C(C=CC(=C1)C(=O)O)O |
TCMBANKIN061628 |
Lariciresinol |
27003-73-2; NSC329247; lariciresinol; 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenol; Lariciresinol, (+)-; 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxy-phenyl)methyl]-3-(hydroxymethyl)tetrahydrofuran-2-yl]-2-methoxy-phenol; 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxy-phenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxy-phenol; 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)-2-tetrahydrofuranyl]-2-methoxyphenol; 4-[(2S,3R,4R)-4-(4-hydroxy-3-methoxy-benzyl)-3-methylol-tetrahydrofuran-2-yl]-2-methoxy-phenol; C10646; Arbo 4; (+)-lariciresinol |
C20H24O6 |
360.4 g/mol |
COC1=C(C=CC(=C1)CC2COC(C2CO)C3=CC(=C(C=C3)O)OC)O |
TCMBANKIN061745 |
syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid |
I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy- |
C9H10O5 |
198.17 g/mol |
COC1=CC(=CC(=C1O)OC)C(=O)O |